These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 26146919

  • 1. A Methodological Appraisal of Recent Real-World Data Publications on Dabigatran.
    Zint K, Kreuzer J.
    JAMA Intern Med; 2015 Jul; 175(7):1244. PubMed ID: 26146919
    [No Abstract] [Full Text] [Related]

  • 2. One-Year Risk of Bleeding With Dabigatran in Patients With Atrial Fibrillation: Placing Real-World Results Into Perspective.
    Miyares MA.
    JAMA Intern Med; 2015 Jul; 175(7):1242-3. PubMed ID: 26146916
    [No Abstract] [Full Text] [Related]

  • 3. The importance of postapproval data for dabigatran.
    Redberg RF.
    JAMA Intern Med; 2015 Jan; 175(1):25. PubMed ID: 25365377
    [No Abstract] [Full Text] [Related]

  • 4. Atrial fibrillation: Risk of bleeding with dabigatran versus warfarin particularly high in CKD.
    Carney EF.
    Nat Rev Nephrol; 2015 Jan; 11(1):3. PubMed ID: 25421829
    [No Abstract] [Full Text] [Related]

  • 5. Patient Characteristics and Risk of Bleeding With Dabigatran in Atrial Fibrillation.
    Henriksen DP, Hansen MR, Damkier P.
    JAMA Intern Med; 2015 Jul; 175(7):1245. PubMed ID: 26146921
    [No Abstract] [Full Text] [Related]

  • 6. Dosage of Dabigatran as a Risk Factor for Bleeding in Atrial Fibrillation.
    Liu S, Kim CO, Lucyk SN.
    JAMA Intern Med; 2015 Jul; 175(7):1244-5. PubMed ID: 26146920
    [No Abstract] [Full Text] [Related]

  • 7. [Dabigatran and risk of bleeding].
    Hasler S.
    Praxis (Bern 1994); 2015 Jan 28; 104(3):157-8. PubMed ID: 25626386
    [No Abstract] [Full Text] [Related]

  • 8. The Role of Selection in the Risk of Bleeding With Dabigatran in Patients With Atrial Fibrillation.
    Klil-Drori A, Azoulay L.
    JAMA Intern Med; 2015 Jul 28; 175(7):1243-4. PubMed ID: 26146918
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risk of bleeding with dabigatran in atrial fibrillation.
    Hernandez I, Baik SH, Piñera A, Zhang Y.
    JAMA Intern Med; 2015 Jan 28; 175(1):18-24. PubMed ID: 25365537
    [Abstract] [Full Text] [Related]

  • 13. Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation.
    Larsen TB, Gorst-Rasmussen A, Rasmussen LH, Skjøth F, Rosenzweig M, Lip GY.
    Am J Med; 2014 Jul 28; 127(7):650-656.e5. PubMed ID: 24530792
    [Abstract] [Full Text] [Related]

  • 14. Letter by Govindarajan and Salgado regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial".
    Govindarajan R, Salgado E.
    Circulation; 2012 Jan 24; 125(3):e290; author reply e293-4. PubMed ID: 22271856
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Letter by Reynolds et al regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial".
    Reynolds S, Parra D, Rosenstein RS.
    Circulation; 2012 Jan 24; 125(3):e291; author reply e293-4. PubMed ID: 22271857
    [No Abstract] [Full Text] [Related]

  • 18. [New anticoagulants, new emergencies?].
    Djalali S.
    Praxis (Bern 1994); 2013 Jul 24; 102(15):945-6. PubMed ID: 23876694
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Management and outcomes of major bleeding during treatment with dabigatran or warfarin.
    Majeed A, Hwang HG, Connolly SJ, Eikelboom JW, Ezekowitz MD, Wallentin L, Brueckmann M, Fraessdorf M, Yusuf S, Schulman S.
    Circulation; 2013 Nov 19; 128(21):2325-32. PubMed ID: 24081972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.